ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Onconova Submits Application for Rigosertib to Participate in COVID-19 Human Studies
July 31, 2020Onconova Therapeutics has submitted an application with the National Institute of Allergy and Infectious Disease (NIAID), with the goal of obtaining funding from the National Institutes of Health (NIH) to conduct human studies with rigosertib in COVID-19.
Pharma Sources Insight January 2025
